Dunn RL - Search Results

1

Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.

Mackler NJ, Dunn RL, Hellerstedt B, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC. Mackler NJ, et al. Among authors: dunn rl. Cancer. 2006 Jun 15;106(12):2617-23. doi: 10.1002/cncr.21927. Cancer. 2006. PMID: 16691618 Free article. Clinical Trial.

2

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

Smith DC, Dunn RL, Strawderman MS, Pienta KJ. Smith DC, et al. Among authors: dunn rl. J Clin Oncol. 1998 May;16(5):1835-43. doi: 10.1200/JCO.1998.16.5.1835. J Clin Oncol. 1998. PMID: 9586898 Clinical Trial.

3

Relationship of serum sex-steroid hormones and prostate volume in African American men.

Joseph MA, Wei JT, Harlow SD, Cooney KA, Dunn RL, Jaffe CA, Montie JE, Schottenfeld D. Joseph MA, et al. Among authors: dunn rl. Prostate. 2002 Dec 1;53(4):322-9. doi: 10.1002/pros.10154. Prostate. 2002. PMID: 12430143 Free article.

4

Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.

Miller DC, Litwin MS, Sanda MG, Montie JE, Dunn RL, Resh J, Sandler H, Wei JT. Miller DC, et al. Among authors: dunn rl. Cancer. 2003 Mar 15;97(6):1428-35. doi: 10.1002/cncr.11216. Cancer. 2003. PMID: 12627506 Free article.

5

Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.

Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. Redman BG, et al. Among authors: dunn rl. Clin Cancer Res. 2003 May;9(5):1666-72. Clin Cancer Res. 2003. PMID: 12738719 Clinical Trial.

6

Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.

Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JM, James SA, Cooney KA, Doerr KM, Montie JE, Schottenfeld D. Joseph MA, et al. Among authors: dunn rl. Am J Epidemiol. 2003 May 15;157(10):906-14. doi: 10.1093/aje/kwg051. Am J Epidemiol. 2003. PMID: 12746243

7

Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.

Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, Lieber MM, Cooney KA, Schottenfeld D, Montie JE, Jacobsen SJ; Olmsted County Study of Urinary Symptoms and Health Status; Flint Men's Health Study. Sarma AV, et al. Among authors: dunn rl. Urology. 2003 Jun;61(6):1086-91. doi: 10.1016/s0090-4295(03)00154-7. Urology. 2003. PMID: 12809866

8

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Fu Z, et al. Among authors: dunn rl. J Natl Cancer Inst. 2003 Jun 18;95(12):878-89. doi: 10.1093/jnci/95.12.878. J Natl Cancer Inst. 2003. PMID: 12813171

9

Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.

Miller DC, Zheng SL, Dunn RL, Sarma AV, Montie JE, Lange EM, Meyers DA, Xu J, Cooney KA. Miller DC, et al. Among authors: dunn rl. Cancer Res. 2003 Jul 1;63(13):3486-9. Cancer Res. 2003. PMID: 12839931

10

Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.

Smith DC, Chay CH, Dunn RL, Fardig J, Esper P, Olson K, Pienta KJ. Smith DC, et al. Among authors: dunn rl. Cancer. 2003 Jul 15;98(2):269-76. doi: 10.1002/cncr.11494. Cancer. 2003. PMID: 12872344 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters